Over the past 12 months, $TAK has been mentioned 13 times by 3 distinct FinTwit voices, with the first mention appearing on September 8, 2025. Jacob Plieth (@jacobplieth) dominates the discussion with 11 mentions, followed by Adam Feuerstein (@adamfeuerstein) with 2 mentions and Nezih Gökay (@nezih_gokay) with 1 mention. The biotech category represents the most active voice category for this ticker.

The most recent mention occurred on June 29, 2026, when Nezih Gökay included Takeda Pharmaceutical in a historical overview of century-old companies trading on U.S. exchanges, noting that the company "started as a small shop selling traditional medicinal herbs in Japan in 1781" and has grown to become "one of Asia's largest and the world's leading biopharmaceutical giants." Jacob Plieth's contributions have focused on specific drug development and acquisition activity within Takeda's portfolio, including discussion of the Servier acquisition of DAWN and speculation about potential future acquisitions.